History | Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 235 KB)

Published:

12 July 2017

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 220 KB)

Published:

09 June 2017
Committee papers (PDF 2.26 MB)

Published:

09 June 2017
Public committee slides (PDF 483 KB)

Published:

09 June 2017

Draft guidance

Draft guidance
Appraisal consultation document (PDF 189 KB)

Published:

17 March 2017
Committee papers (PDF 23.7 MB)

Published:

17 March 2017
Public committee slides (PDF 1.41 MB)

Published:

17 March 2017

Assessment report sent for information

Assessment report (PDF 6.03 MB)

Published:

20 January 2017

Invitation to participate

Final scope (PDF 107 KB)

Published:

27 June 2016
Final matrix (PDF 89 KB)

Published:

27 June 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 185 KB)

Published:

27 June 2016
Equality impact assessment (Scoping) (PDF 134 KB)

Published:

27 June 2016
Final protocol (PDF 272 KB)

Published:

27 June 2016

Draft scope documents

Draft scope (pre-referral) (PDF 114 KB)

Published:

27 November 2015
Provisional matrix (pre-referral) (PDF 100 KB)

Published:

27 November 2015